NCT00902135View on ClinicalTrials.gov

Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)

CompletedOBSERVATIONAL
Enrollment

702

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

August 31, 2014

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Interferon beta-1b (Betaferon) and Personal Digital Assistant together with a reminder

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Interferon beta-1b (Betaferon) and Personal Digital Assistant without a reminder

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Interferon beta-1b (Betaferon)

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY